glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Lipsitz, Ponterio & Comerford |
Description
Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials
![glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Lipsitz, Ponterio & Comerford |](https://lipsitzponterio.com/wp-content/uploads/2026/02/GLP-1-Lawsuit-in-New-York-Lipsitz-Ponterio-Comerford-LLC.png)
It correlates with the rate and amount of weight loss
![glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Lipsitz, Ponterio & Comerford |](https://www.leoninefocus.com/wp-content/uploads/2025/10/Legal-Financing-Content-Visual-1-1200x800.png)
Many GLP-1 users need the higher end of supplementation
![glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Lipsitz, Ponterio & Comerford |](https://www.foley.com/wp-content/uploads/2025/02/glp1injection.jpg)
Traditional in-person endocrinology or primary-care prescribing may offer deeper evaluation but longer wait times
![glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Lipsitz, Ponterio & Comerford |](https://www.primetherapeutics.com/documents/9647575/10909131/7645_GLP-1+Pipeline_1280x720.png/857bd3bb-f724-67bd-a8df-42b9ecd464d0?version=1.0&t=1765821206200)
Patients facing high OOP costs often discontinue therapy prematurely or dose less frequently to stretch prescriptions
![glp-1 lawsuit news today 2025 Ozempic [July 2026 Update] Lipsitz, Ponterio & Comerford |](https://www.lmiweb.com/sites/default/files/inline-images/Top%205%20PL%20Lawsuits_list-images%20%281%29_2.png)